{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:06:16Z","timestamp":1790165176240,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.prnil.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:46:38Z","timestamp":1778827598000},"page":"260-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infectious complications after transrectal prostate biopsy in Algeria: A prospective study in a high-resistance setting"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7334-4144","authenticated-orcid":false,"given":"Samir","family":"Bouras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prnil.2026.05.001_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prnil.2026.05.001_bib2","series-title":"Algeria fact sheet 2022 [Internet]","year":"2022"},{"issue":"4","key":"10.1016\/j.prnil.2026.05.001_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1007115312039","article-title":"Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of single-dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole","volume":"31","author":"Isen","year":"1999","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"10.1016\/j.prnil.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1464-410x.2000.00576.x","article-title":"Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study","volume":"85","author":"Aron","year":"2000","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.prnil.2026.05.001_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.prnil.2026.05.001_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/JU.0000000000000814","article-title":"Antibiotic prophylaxis for prevention of infectious complications following prostate biopsy: systematic review and meta-analysis","volume":"204","author":"Pilatz","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.prnil.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bju.15039","article-title":"Comparison of complications after transrectal and transperineal prostate biopsy: a national population-based study","volume":"126","author":"Berry","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.prnil.2026.05.001_bib8","article-title":"EAU\u2013EANM\u2013ESTRO\u2013ESUR\u2013ISUP\u2013SIOG guidelines on prostate cancer 2025 [Internet]","author":"Cornford","year":"2025","journal-title":"Arnhem: European Assoc Urol"},{"key":"10.1016\/j.prnil.2026.05.001_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.prnil.2023.11.003","article-title":"Shifting to transperineal prostate biopsy: a narrative review","volume":"12","author":"Chung","year":"2024","journal-title":"Prostate Int"},{"issue":"4","key":"10.1016\/j.prnil.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4111\/icu.20250077","article-title":"Patient-reported outcome measures for pain and tolerability of transperineal prostate biopsy under local anaesthesia using the PrecisionPoint transperineal access system: a prospective study for a real-world patient experience","volume":"66","author":"Albnhawy","year":"2025","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.prnil.2026.05.001_bib11","series-title":"20e rapport d\u2019\u00e9valuation 2019 (actualis\u00e9 2021) [Internet]","year":"2021"},{"issue":"3","key":"10.1016\/j.prnil.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi","year":"2017","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.prnil.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/iju.13883","article-title":"Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: prospective randomized study","volume":"26","author":"Van Besien","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.prnil.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prnil.2024.10.005","article-title":"Single-dose vs prolonged antibiotic prophylaxis of fosfomycin for transrectal prostate biopsy","volume":"13","author":"Feh\u00e9r","year":"2025","journal-title":"Prostate Int"},{"issue":"5","key":"10.1016\/j.prnil.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.micinf.2005.12.016","article-title":"The systemic inflammatory response syndrome","volume":"8","author":"Robertson","year":"2006","journal-title":"Microb Infect"},{"key":"10.1016\/j.prnil.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of effects of antibiotic consumption on resistance","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.prnil.2026.05.001_bib17","series-title":"Antimicrobial resistance fact sheet [Internet]","year":"2023"},{"key":"10.1016\/j.prnil.2026.05.001_bib18","article-title":"EAU guidelines on urological infections [Internet]","author":"Bonkat","year":"2023","journal-title":"Arnhem: European Assoc Urol"},{"issue":"3","key":"10.1016\/j.prnil.2026.05.001_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1473-3099(10)70027-X","article-title":"Antibiotic prescribing in hospitals: a social and behavioural scientific approach","volume":"10","author":"Hulscher","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.prnil.2026.05.001_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-020-02884-3","article-title":"Why big pharma has abandoned antibiotics","volume":"586","author":"Plackett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.prnil.2026.05.001_bib21","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/S2468-2667(22)00225-0","article-title":"Burden of bacterial antimicrobial resistance in the WHO European region in 2019","volume":"7","author":"Mestrovic","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.prnil.2026.05.001_bib22","series-title":"Fluoroquinolone and quinolone antibiotics: PRAC recommends restrictions on use [Internet]","year":"2018"},{"key":"10.1016\/j.prnil.2026.05.001_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/antibiotics13100940","article-title":"Amoxicillin\/clavulanic acid in transrectal biopsy of the prostate","volume":"13","author":"Spachmann","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.prnil.2026.05.001_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00345-024-04969-4","article-title":"Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy","volume":"42","author":"Jahnen","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.prnil.2026.05.001_bib25","article-title":"Cephalosporin monoprophylaxis after fluoroquinolone era","volume":"11","author":"Wenzel","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.prnil.2026.05.001_bib27","first-page":"e80","article-title":"Ciprofloxacin alone vs ciprofloxacin plus fosfomycin","volume":"18","author":"Albers","year":"2024","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.prnil.2026.05.001_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/antibiotics11030415","article-title":"Comparison of fluoroquinolones and other prophylaxis regimens","volume":"11","author":"Tulone","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.prnil.2026.05.001_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.prnil.2024.11.006","article-title":"Gentamicin plus ciprofloxacin reduces infection rates post biopsy","volume":"13","author":"Guduguntla","year":"2025","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2026.05.001_bib30","first-page":"102","article-title":"Meta-analysis of methods to reduce infectious complications following prostate biopsy","volume":"145","author":"Jazayeri","year":"2020","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.prnil.2026.05.001_bib31","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.euf.2021.11.007","article-title":"Fosfomycin trometamol for prevention of infectious complications after prostate biopsy: consensus statement","volume":"8","author":"Bjerklund Johansen","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.prnil.2026.05.001_bib32","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.5489\/cuaj.3068","article-title":"Prophylactic single-dose fosfomycin in transrectal biopsy: randomized study","volume":"9","author":"Sen","year":"2015","journal-title":"Can Urol Assoc J"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888226000346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888226000346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:47:10Z","timestamp":1790164030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888226000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2287888226000346"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2026.05.001","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious complications after transrectal prostate biopsy in Algeria: A prospective study in a high-resistance setting","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}